Cancer Medicine Price Cut From 9 November 2026: New MRP List and Price Checker

Health & money · Updated 9 November 2026

Cancer Medicine Price Cut: 1,085 brands cheaper from 9 November. Check yours

The government has capped trade margins on 137 cancer medicines, and the new, lower MRPs apply from today. Some prices fell by more than 90%. Use the checker to see what your medicine costs now and how much you save in a year.

💊
The short answer
  • From 9 November 2026, revised (lower) MRPs apply to cancer medicines covered by the National Pharmaceutical Pricing Authority’s (NPPA) order of 17 October.
  • The order caps trade margins at 30% for 137 non-scheduled anti-cancer drugs, including pembrolizumab, nivolumab, osimertinib, bevacizumab, denosumab and pegfilgrastim.
  • NPPA’s list had 543 brands with cut prices on 28 October, updated to 1,085 brands on 3 November. The government expects prices to fall by up to 70% and patients to save about ₹2,500 crore a year.
  • Biggest cuts reported: Palbopro (palbociclib) from ₹40,421 to ₹2,720, and Samtepa (thiotepa) from ₹80,072 to ₹7,150.
  • Your chemist or hospital must charge the new price from today. Check it on the Pharma Sahi Daam app, and report overcharging to NPPA on 1800-111-255.

Cancer medicine price checker

Type a brand or generic name. See the old and new MRP, what you save per month and per year, and whether your chemist is charging too much.

Try Palbopro, Dasanat 20, bevacizumab, denosumab
For injections, use doses per month
Leave blank if you have not bought it yet
For medicines not in our table, we estimate a 30% to 70% saving

Cancer treatment in India is often paid out of pocket, and a single month of a targeted drug or immunotherapy can cost more than a family earns in a year. A large part of that price has been the margin paid to distributors, retailers and hospitals. This order goes after exactly that margin, which is why some brands have fallen so sharply.

What the cancer medicine price cut means for you: the cancer medicine price cut applies at the counter, not just on paper. A patient on palbociclib could save over ₹4.5 lakh a year on one brand alone. The cancer medicine price cut also lowers what insurers pay, which helps your cover last longer, and it pushes hospitals to publish their medicine prices. But the size of the cancer medicine price cut varies widely by brand, so check yours before you buy.

Cancer medicine price cut list: old vs new MRP

These are the brands for which the old and new MRPs have been reported, from NPPA’s lists of 28 October and 3 November. Prices are per pack and include GST.

Brand (company)Medicine and packOld MRPNew MRPCut

NPPA’s full list runs to more than a thousand entries and will be updated as companies send revised prices, so check the latest list for your exact pack.

How the 30% trade margin cap works

A trade margin is the gap between what the manufacturer charges the stockist (the price to stockist) and the MRP you pay. On some cancer drugs, that gap was several times the factory price, because brands competed by offering large margins to hospitals and chemists rather than by cutting prices.

Under the order, the MRP can now be at most the price to stockist plus a margin of 30% of the MRP. In the government’s example, if the price to stockist is ₹70, the maximum MRP is ₹100, before GST. Companies had to work out revised prices using their March 2026 distributor prices and report them to NPPA within seven days of the notification.

Why some brands barely changed: if a brand already had a small margin, the cap changes little. Pfizer’s Crizalk (crizotinib) fell only about 6.6%. Of 56 products with an MRP above ₹1 lakh, only three were cut in the first list, according to an analysis of NPPA data.

The power comes from Paragraph 19 of the Drugs (Prices Control) Order, 2013, which lets the government act on drug prices in the public interest. It has been used before: in 2019, a 30% margin cap on 42 cancer drugs cut the MRPs of 526 brands by up to 90%.

Which cancer drugs are covered?

The 137 drugs were picked by an expert committee under the Directorate General of Health Services. They include immunotherapies used for more than 20 types of cancer. Drugs named in official and news reports include:

GroupDrugs named
ImmunotherapyPembrolizumab, nivolumab, durvalumab, atezolizumab, toripalimab
Antibody drugsBevacizumab, trastuzumab combinations, pertuzumab, daratumumab, amivantamab, denosumab
Targeted tablets and capsulesOsimertinib, palbociclib, ribociclib, abemaciclib, olaparib, lenvatinib, sunitinib, afatinib, alectinib, crizotinib, ibrutinib, acalabrutinib, zanubrutinib, venetoclax, dasatinib
Hormone therapyAbiraterone acetate, enzalutamide, anastrozole
Chemotherapy and supportAzacitidine, thiotepa, pegfilgrastim (prevents low white blood cell counts during chemo)

This is not the full list of 137. If your medicine is not here, it may still be covered, so check its brand on the Pharma Sahi Daam app or NPPA’s website.

What patients should do from 9 November

  1. Check the new MRP before you pay. Search the brand on the Pharma Sahi Daam app (Android and iOS) or NPPA’s website. The checker above covers the brands with published prices.
  2. Ask for the revised price, even on old stock. From 9 November, chemists and hospitals must charge the revised price and display updated rates. Hospitals must also publish them on their websites.
  3. Keep your bill. It must show the brand, batch and price charged.
  4. Report overcharging. Call NPPA’s toll-free number 1800-111-255 or file a complaint on its Pharma Jan Samadhan portal. NPPA can make companies refund the excess with interest.
  5. Do not switch brands on your own. If a cheaper brand of the same drug is now available, ask your oncologist before changing, especially for biologic drugs.

Tax tip: under the old tax regime, Section 80DDB lets you deduct the cost of treating cancer for yourself or a dependant, up to ₹40,000 a year (₹1 lakh for senior citizens), minus any insurance payout. Our old vs new tax regime calculator shows whether the old regime works out better for you.

Cancer medicine price cut: FAQs

From when are cancer medicines cheaper?

From 9 November 2026. NPPA notified the 30% trade margin cap on 17 October, published the first revised price list on 28 October and updated it on 3 November.

How many cancer medicines got cheaper?

The cap covers 137 drugs (molecules). NPPA’s revised list covered 543 brands on 28 October and 1,085 brands on 3 November, and it will keep growing as companies report prices.

How much cheaper are cancer drugs now?

The government expects falls of up to 70%. Some brands fell more than 90%, such as Palbopro (₹40,421 to ₹2,720), while some costly patented brands changed very little.

Can a chemist sell old stock at the old MRP?

No. From 9 November, chemists and hospitals must charge the revised price, whatever is printed on the old pack. If you are overcharged, keep the bill and call NPPA on 1800-111-255.

How can I check the new price of my medicine?

Use the government’s Pharma Sahi Daam app or NPPA’s website, which list the revised MRP by brand and pack. The checker on this page also covers the brands whose prices have been reported.

Sources

This page explains a government pricing order for general information. It is not medical advice. Prices are from NPPA lists as reported up to 3 November 2026 and can change as the list is updated; always confirm the current MRP on the Pharma Sahi Daam app or NPPA’s website, and talk to your doctor before changing any medicine. WellthRise is not affiliated with NPPA or any drug company.

Cancer medicine price cut: tablets in a blister pack
Photo by Christine Sandu on Unsplash
WR
Written and fact-checked by
WellthRise Editorial Team

We write practical guides on money, tax, salary, wellness and India news. Rates, rules and dates come from official sources such as RBI, SEBI, the Income Tax Department, India Code and government notifications, linked in each article with the date we last checked them. We don’t accept payment to change what we write.

Our editorial policyReport an error

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top